Haemodynamic effects of etomidate, propofol and electrical shock in patients undergoing implantable cardioverter-defibrillator testing

Kardiologia Polska

Volumn 72, Issue 8, 2014, Pages 707-715

  Zgoła, Katarzyna ^a   Kułakowski, Piotr ^a   Czepiel, Aleksandra ^a   Świa̧tkowski, Maciej ^a   Makowska, Ewa ^a   Błachnio, Elzbieta ^a   Soszyńska, Małgorzata ^a   Misiewicz, Magdalena ^a  

^a GROCHOWSKI HOSPITAL   (Poland)

Author keywords

Etomidate; Haemodynamic parameters; Impedance cardiography; Internal electrical shock; Propofol

Indexed keywords

ETOMIDATE; PROPOFOL; HYPNOTIC SEDATIVE AGENT;

AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEFIBRILLATION; DIASTOLIC BLOOD PRESSURE; ELECTRIC SHOCK; FEMALE; HEART HEMODYNAMICS; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPEDANCE CARDIOGRAPHY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NEW YORK HEART ASSOCIATION CLASS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE; CARDIOVERSION; DRUG EFFECTS; HEMODYNAMICS; MIDDLE AGED; UTILIZATION;

AGED; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ETOMIDATE; FEMALE; HEMODYNAMICS; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PROPOFOL; STROKE VOLUME;

EID: 84906883431     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: 10.5603/KP.a2014.0086     Document Type: Article

References (45)

1. Denny MA, Manson R, Della-Giustina D. Propofol and etomidate are safe for deep sedation in the Emergency Department. West J Emerg Med, 2011; 12: 399-403.
2. Kalogridaki M, Souvatzis X, Mavrakis HE et al. Anaesthesia for cardioversion: a prospective randomised comparison of propofol and etomidate combined with fentanyl. Hellenic J Cardiol, 2011; 52: 483-488.
3. Siedy J, Knapik R, Saucha W, Gross M. Comparison of propofol and etomidate anaesthesia for elective electrical cardioversion. Kardiol Pol, 2010; 68: 1249-1255.
4. Hullander RM, Leivers D, Wingler K. A comparison of propofol and etomidate for cardioversion. Anaesth Analg, 1993; 77: 690-694.
5. Bendel S, Ruokonen E, Polonen P, Uusaro A. Propofol causes more hypotension than etomidate in patients with severe aortic stenosis: a double-blind, randomized study comparing propofol and etomidate. Acta Anaesthesiol Scand, 2007; 51: 284-289.
6. Reich DL, Hossain S, Krol M et al. Predictors of hypotension after induction of general anesthesia. Anesth Analg, 2005; 101: 622-628.
7. Ebert J, Muzi M, Berens R et al. Sympathetic responses to induction of anesthesia in humans with propofol or etomidate. Anesthesiology, 1992; 76: 725-733.
8. Kick O, Kessler J, Conradi R et al. Anesthesia for outpatient cardioversion hypnomidate versus propofol. Anesthesiology, 1993; 70: 3A.
9. Canessa R, Lema G, Urzula J et al. Anesthesia for elective cardioversion: a comparison of four anesthetic agents. J Cardiothorac Vasc Anesth, 1991; 5: 566-568.
10. Moller Petrun A, Kamenik M. Bispectral index - guided induction of general anaesthesia in patients undergoing major abdominal surgery using propofol or etomidate: a double-blind, randomized, clinical trial. Br J Anaesth, 2013; 110: 388-396.
11. Wu J, Yao S, Wu Z et al. A comparison of anesthetic regimens using etomidate and propofol in patients undergoing first-trimester abortions: double-blind, randomized clinical trial of safety and efficiacy. Contraception, 2013; 87: 55-62.
12. Weng D, Huang M, Jiang R et al. Clinical study of etomidate emulsion combined with remifentanyl in general anesthesia. Drug Design, Development Therapy, 2013; 7: 771-776.
13. Toklu S, Iyilikci L, Gonen C et al. Comparison of etomidate-remifentanil and propofol-remifentanil sedation in patients scheduled for colonoscopy. Eur J Anaesthesiol, 2009; 26: 370-376.
14. Boisson-Bertrand D, Taron F, Laxenaire MC. Etomidate vs. propofol to carry out suspension laryngoscopies. Eur J Anaesthesiol, 1991; 8: 141-144.
15. Herregods LL, Bossuyt GP, Baerdemaeker LE et al. Ambulatory electrical external cardioversion with propofol or etomidate. J Clin Anesth, 2003; 15: 91-96.
16. Mitterschiffthaler G, Lechleitner P, Hauptlorenz S et al. Anesthesia for cardioversion. A comparison of propofol and etomidate. Cah Anesthesiol, 1990; 38: 159-163.
17. Singh R, Choudhury M, Kapoor PM, Kiran U. A randomized trial of anesthetic induction agents in patients with coronary artery disease and left ventricular dysfunction. Ann Card Anaesth, 2010; 13: 217-223.
18. Miner JR, Danahy M, Moch A, Biros M. Randomized clinical trial of etomidate versus propofol for procedural sedation in the Emergency Department. Ann Emerg Med, 2007; 49: 15-22.
19. Morel J, Salard M, Castelain C et al. Haemodynamic consequences of etomidate administration in elective cardiac surgery: a randomized double-blinded study. BJA, 2011; 107: 503-509.
20. Dennis CJ, Chung KK, Holland SR et al. Risk factors for hypotension in urgently intubated burn patients. Burns, 2012; 38: 1181-1185.
21. Tan HL, Lee CY. Comparison between the effects of propofol and etomidate on motor and electroencephalogram seizure duration during electroconvulsive therapy. Anaesth Intensive Care, 2009; 37: 807-814.
22. Wilhelm W, Biedler A, Huppert A et al. Comparison of the effects of remifentanil or fentanyl on anaesthetic induction characteristics of propofol, thiopental or etomidate. Eur J Anaesthesiol, 2002; 19: 350-356.
23. Meyer J, Möllhoff T, Seifert T et al. Cardiac output is not affected during intraoperative testing of the automatic implantable cardioverter- defibrillator. J Cardiovasc Electrophysiol, 1996; 7: 211-216.
24. Skhirtladze K, Mora B, Moritz A et al. Impaired recovery of cardiac output and mean arterial pressure after successful defibrillation in patients with low left ventricular ejection fraction. Resuscitation, 2010; 81: 1123-1127.
25. Toh N, Nishii N, Nakamura K et al. Cardiac dysfunction and prolonged hemodynamic deterioration after implantable cardioverter-defibrillator shock in patients with systolic heart failure. Circ Arrhythm Electrophysiol, 2012; 5: 898-905.
26. Cybulski G, Kozluk E, Michalak E et al. Holter-type impedance cardiography device. A system for continuous and non-invasive monitoring of cardiac haemodynamics. Kardiol Pol, 2004; 61: 138-146.
27. Gimbel JR. Method and demonstration of direct confirmation of response to cardiac resynchronization therapy via preimplant temporary biventricular pacing and impedance cardiography. Am J Cardiol, 2005; 96: 874-876.
28. Fortin J, Habenbacher W, Heller A et al. Non-invasive beat-to-beat cardiac output monitoring by an improved method of transthoracic bioimpedance measurement. Comput Biol Med, 2006; 36: 1185-1203.
29. Thomas B, Meirlaen L, Rolly G, Weyne L. Clinical use of etomidate. Acta Anaesthesiol Belg, 1976; 27 (suppl): 167-174.
30. Kardos A, Földesi C, Nagy A et al. Trendelenburg positioning does not prevent a decrease in cardiac output after induction of anaesthesia with propofol in children. Acta Anaesthesiol Scand, 2006; 50: 869-874.
31. Krzesiński P, Michałkiewicz D, Orski Z et al. Is haemodynamic evaluation with impedance cardiography in patients with heart failure undergoing testing of the implanted cardioverter-defibrillator of clinical importance? Kardiol Pol, 2011; 69: 548-556.
32. Coll-Vinent B, Sala X, Fernandez C et al. Sedation for cardioversion in the Emergency Department: analysis of effectiveness in four protocols. Ann Emerg Med, 2003; 42: 767-772.
33. Pacificio A, Cedillo-Salazar FR, Nasir N Jr et al. Conscious sedation with combined hypnotic agents for implantation of implantable cardioverter-defibrillators. J Am Coll Cardiol, 1997; 30: 769-773.
34. Brussel T, Theissen JL, Vigfusson G et al. Hemodynamic and cardiodynamic effects of propofol and etomidate: negative inotropic properties of propofol. Anesth Analg, 1989; 69: 35-40.
35. Lam CF, Chang PJ, Chen YA et al. Inhibition of ATP-sensitive potassium channels attenuates porpofol-induced vasorelaxation. Crit Care Resusc, 2010; 12: 186-190.
36. Gursoy S, Berkan O, Bagcivan I et al. Effects of intravenous anesthetics on the human radial artery used as a coronary artery bypass graft. J Cardiothorac Vasc Anesth, 2007; 21: 41-44.
37. Camci E, Koltka K, Sungur Z et al. Implantable cardioverter-defibrillator placement in patients with mild-to-moderate left ventricular dysfunction: hemodynamics and recovery profile with two defferent anesthetics used during deep sedation. J Cardiothorac Vasc Anesth, 2003; 17: 613-616.
38. Davoodi G, Mohammadi V, Shafiee A et al. Detection of myocardial injury due to defibrillation threshold checking after insertion of implantable cardioverter/defibrillators. Acta Cardiol, 2013; 68: 167-172.
39. Mollerus M, Naslund L. Myocardial stunning following defibrillation threshold testing. J Interv Card Electrophysiol, 2007; 19: 213-216.
40. Birnie D, Tung S, Simpson C et al. Complications associated with defibrillation threshold testing: the Canadian experience. Heart Rhythm, 2008; 5: 387-390.
41. Pandya K, Patel MB, Natla J et al. Predictors of hemodynamic compromise with propofol during defibrillator implantation: a single center experience. J Interv Card Electrophysiol, 2009; 25: 145-151.
42. Stefano B, Pietro RR, Maurizio G et al. Defibrillation testing during implantable cardioverter-defibrillator implantation in Italian current practice: the Assessment of Long-term Induction clinical ValuE (ALIVE) project. Am Heart J, 2011; 162: 390-397.
43. Vischer AS, Sticherling C, Kühne MS et al. Role of defibrillation threshold testing in the contemporary defibrillator patient population. J Cardiovasc Electrophysiol, 2013; 24: 437-441.
44. Keyser A, Hiker MK, Schmidt S et al. Shock or no shock: a question of philosophy or should intraoperative implantable cardioverter-defibrillator testing be recommended? Interact Cardiovasc Thorac Surg, 2013; 16: 321-325.
45. Albert NM, Hail MD, Li J, Young JB. Equivalence of the bioimpedance and thermodilution methods in measuring cardiac output in hospitalized patients with advanced, decompensated chronic heart failure. Am Crit Care, 2004; 13: 469-479.